StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
195990.KQ$1005.00-3.46%
Fair $1005.00+0.0%

195990.KQ

Abpro Bio Co., Ltd.

Industrials / Specialty Industrial MachineryKOSDAQ

$1005.00

-36.00 (-3.46%)

Fairly Valued+0.0%Fair Value $1005.00Fund rank 31/100 · Data gapFallback financials|
SA 20/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 24%

FCF escenarios

weak_data · normalized FCF $-9.0B · quality 73.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 38/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -90.5%, below the 5% threshold
Thesis & Journal · 195990.KQLocal privado en este navegador · Abpro Bio Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$28.6B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-90.5%

↓

Gross Margin

11.0%

↓

Debt/Equity

0.29

↓
52-Week Range$1005
$992$4470

TradingView lightweight chart

195990.KQ price, volumen y niveles de valoración

Último $1,005Periodo -97.6%
Fair value: $1,005

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+13.0%

FCF CAGR

—

FCF margin

-28.1%

FCF / Net income

0.18x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $31.92B · net income $-48.92B · FCF $-8.99B

2022-FY → 2025-FY

Gross margin

11.0%+3.7% pts

Operating margin

-29.1%+16.0% pts

Net margin

-153.2%-116.4% pts

FCF margin

-28.1%+38.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$31.92B$31.92B$31.66B$25.38B$22.11B
Net Income$-48.92B$-48.92B$-15.63B$-25.74B$-8.14B
EBITDA$-46.27B$-46.27B$-12.48B$-21.45B$-2.15B
EPS-1718.40-1718.40-579.90-925.10-303.60
Gross Margin11.0%11.0%1.9%5.0%7.3%
Operating Margin-29.1%-29.1%-20.5%-34.7%-45.1%
Net Margin-153.2%-153.2%-49.4%-101.4%-36.8%
Balance Sheet
Debt/Equity0.290.290.200.100.08
Current Ratio3.153.15———
Cash Flow
Free Cash Flow$-8.99B$-8.99B$-22.88B$-7.10B$-14.81B
Returns
ROE-90.5%-90.5%-14.5%-21.0%-5.8%
Valuation
P/B0.530.531.091.350.83
Growth & Yield
Revenue Growth0.8%0.8%24.8%14.8%—
EPS Growth-196.3%-196.3%37.3%-204.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -65.5%

Total return

-65.5%

Start / end P/E

n/dx → n/dx

EPS bridge

-579.90 → -1718.40

Residual

-65.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-65.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.